Saskatchewan ends fiscal year with $182M surplus, below original

Saskatchewan ends fiscal year with $182M surplus, below original $182 Sionna secures $182M series C to more than double its clinical-stage cystic fibrosis contenders Sionna Therapeutics has closed a $182 million convert $182 The 6-core Ryzen 5 8600G is no longer listed at $199 The CPU is now available at $182, currently the lowest price for an AM5-based desktop APU

convert $182 Sionna raises another $182M to challenge Vertex in cystic fibrosis The Boston startup has amassed a pipeline of drugs it believes can fully

$182  We value Texas Instruments at about $175 per share, marginally below the current market price of $182 See our analysis of Texas Instruments Penn Medicine Lancaster General Health marked the completion last week of a $182 million expansion of its Lancaster city hospital's trauma